RCKT - Rocket Pharma gains as EU accepts gene therapy for review
2024-04-02 06:55:37 ET
Rocket Pharmaceuticals ( NASDAQ: RCKT ) traded higher premarket Tuesday after the EU drug regulator, the European Medicines Agency (EMA), accepted its marketing application for gene therapy candidate RP-L102 for review....
Rocket Pharma gains as EU accepts gene therapy for review